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Abstract
Introduction and hypothesis To study the prevalence and
risk factors of overactive bladder (OAB) symptoms and its
relationship with symptoms of pelvic organ prolapse (POP).
Methods This is a cross-sectional study including women
aged between 45 and 85 years, registered in eight general
practices. All women were asked to self complete the
validated Dutch translated questionnaires. All symptoms
were dichotomized as present or absent based on responses
to each symptom and degree of bother.
Results Forty-seven percent of the women filled out the
questionnaire. Prevalence of urgency was 34% and the
prevalence of any OAB symptoms 49%. Prevalence of
OAB symptoms increased with advancing age. Symptoms
of POP were an independent risk factor for symptomatic
OAB. Other risk factors were continence and prolapse
surgery in the past, age above 75, overweight, postmeno-
pausal status and smoking.
Conclusions The prevalence of any OAB symptoms was
49%. POP symptoms were an independent risk factor for
symptomatic OAB.
Keywords Overactive bladder.Urgency.Urge
incontinence.Frequency.Pelvic organ prolapse.
Prevalence
Introduction
Pelvic organ prolapse (POP) and overactive bladder (OAB)
symptoms are important problems for women. POP is a
prevalent problem which has been reported to affect 50% of
parous women [1]. Eleven percent of the women will have
undergone an operation for prolapse or urinary incontinence
by the age of 80 [2].
OAB is known to be a highly prevalent disorder that
increases with age in both sexes and that has a profound
impact on quality of life [3]. According to the Interna-
tional Continence Society (ICS) OAB is defined as
urgency with or without urge incontinence, usually with
frequency and nocturia [4]. This term can only be used if
there is no proven infection or ‘obvious pathology’.I ti sa
matter of debate whether POP should be considered as
‘obvious pathology’.
Symptoms of OAB are often seen in patients with
POP [5]. Community based studies showed that the
prevalence of OAB symptoms ish i g h e ri np a t i e n t sw i t h
POP than without POP [5]. The same tendency is found in
hospital based studies [5]. Nevertheless, the literature
about the prevalence of the combination of POP and OAB
is scarce.
To study the relation between POP and OAB, we used
data from a cross-sectional study which was performed in a
small Dutch city about the prevalence of pelvic floor
symptoms in the general population [6].
The objective of this study is to investigate risk factors
for OAB and specifically to explore the relationship
between OAB and prolapse. This is important for clinical
practice because the two diagnoses are often co-occurring
which has possible consequences for diagnosis and
treatment.
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The study was cross-sectional in a small town, Brielle, in
the Netherlands. Brielle was chosen because it has a
homogenic population, where all women are registered in
one of the nine general practices. All women aged 45 to
85 years registered on the patients lists of eight out of nine
general practices were invited to enrol in the study, which is
95% of the women in this age group. The women were sent
information about the study and informed that they could
enrol by filling out an informed consent form. All women
who consented were asked to complete a self-report
questionnaire. Non-responders received a reminder 8 weeks
later that contained the same questionnaire. To check for
selection bias, permanent non-responders were invited to
complete a short questionnaire that comprised five questions
about age, parity, presence of stress urinary incontinence
(yes/no), faecal incontinence (yes/no) and feeling of vaginal
bulging (yes/no). To encourage a high response to the
questionnaire, we used envelopes with the name and logo of
the Erasmus University, coloured paper and stamped
addressed return envelopes.
Three options were possible: women refused to participate
in the study, women filled out only the questionnaire and
women filled out the questionnaire and underwent vaginal
examination. For the purpose of this study, data on vaginal
examination are not used. The relation between symptoms
and signs of vagina prolapse has been extensively described
in an earlier study [6]. A flowchart of the study design is
presented in Fig. 1. In this study, all women who answered
the questionnaires are included.
The self-reported questionnaire used for this study are a
composite of internationally well-known questionnaires
that have been validated for the Dutch language. It
contains, amongst others, disease-specific questions from
the validated Dutch translation of the Urinary Distress
Inventory(UDI) [7] next to other questionnaires and items
which were not used for the present study [6].
Fig. 1 Flowchart of the study
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symptom on a 5-point Likert scale, from 0 (no complaints
at all) to 4 (very serious complaints). In addition,
questions about ethnicity, parity, POP symptoms during
pregnancy, family history, menopausal status, hormone
replacement therapy (HRT), previous pelvic floor surgery,
educational level, smoking and heavy physical work were
also included.
The Medical Ethics Research Committee (METC) of the
Erasmus MC in Rotterdam, the Netherlands, approved this
study.
Measurements
All symptoms were dichotomized as present or absent
based on responses to each symptom and degree of bother
with these symptoms. Women who denied the presence of a
specific symptom as well as women who answered
confirmative on a specific question but answered not to
be bothered by it were considered as negative (absent)
while women who indicated that they were little to severe
bothered were considered as positive (present). The item of
POP symptoms is merged from women who reported
either seeing and/or feeling vaginal bulging. For the item
a n yO A Bs y m p t o m s ,w o m e nw h oh a du r g e n c ya n d / o r
frequency and/or urge incontinence symptoms were
included (see Fig. 2).
Data are presented as number of women (percentage),
mean (standard deviation) or median (range) as appropriate.
Chi-square test was used to compare the difference between
the women with- versus without POP symptoms.
Logistic regression was used for the univariate and
multivariate analysis. For logistic regression, the backward
elimination procedure was used. Variables with a P<0.3 in
univariate analysis were included in the multivariate analysis.
We presented the odds ratio (OR) and 95% CI for each of the
OAB symptoms. The level of significance was set at an
alpha value of 0.05. All data were entered and analysed in a
SPSS 15.0 database for Windows (SPSS, Inc., Chicago, IL).
Results
Of the 2,979 women who were eligible for this study, 1,397
(47%) filled out the questionnaire. In the non-responder
group, 59% filled out and returned the short questionnaire
(620/1,051), giving a total response rate of 62.7% (Fig. 1).
Scores in the short questionnaire group were not significant-
ly different from those in the total study group. Details of the
response rate are presented in a previous report [6].
Table 1 shows the characteristics of the women included
in this study. Table 2 shows the prevalence of OAB
symptoms per age category. In Table 3, the prevalence of
POP symptoms in women with and without OAB symp-
toms is presented.
In Table 4, the various possible risk factors including the
presence of POP symptoms for the presence of OAB
symptoms are presented in a univariate logistic regression
model.
The OR shows the chance of the presence of OAB
symptoms. An OR >1 indicates that the factor is positively
correlated with the outcome variable; an OR <1 means that
the factor indicates a negative correlation.
Table 5 shows the multivariate analysis of the OAB
symptoms where all factors of the univariate analysis with a
P<0.3 are taken into account.
Discussion
In this cross-sectional study, we looked at the prevalence of
OAB symptoms and specifically the relationship between
OABsymptomsandPOPsymptoms.Wefoundaprevalenceof
urgency,frequencyand urge urinary incontinenceof 34%,29%
and 30%, respectively. The prevalence for any OAB symptoms
was 49%. This is comparable with other studies, where a
prevalence of 16.8–49% was found in women [3, 8]. POP
symptoms were present in 11.4%, which is comparable with
other studies where a prevalence of 4–30% was found [9–11].
Risk factors
This study found POP symptoms to be an independent risk
factor for OAB symptoms. The sparse cross-sectional
Fig. 2 Any OAB symptoms in relation to urgency, frequency and
urge incontinence
Int Urogynecol J (2011) 22:569–575 571studies who mentioned a relationship between POP
symptoms and OAB, showed a higher prevalence of OAB
symptoms with POP symptoms than without POP symp-
toms (!) [5] but were not controlled for other risk factors.
The same relationship between POP and OAB is found in
hospital based studies, the prevalence of OAB symptoms is
greater in patients with POP than without POP [5].
However, by the nature of these epidemiological studies a
causal relationship cannot be established. There are many
possible theories regarding the pathophysiology of OAB in
relation to POP and it is likely that bladder obstruction
plays an important role [5]. Nevertheless, several other
mechanisms might be considered. The pathophysiological
relationship between OAB and POP needs to be studied
further. Important clinical implication of the relationship
between POP and OAB is that treatment of POP could give
an improvement in OAB symptoms. This is consistent with
the finding in a recent review [5].
Another important risk factor for OAB symptoms was
surgery for urinary incontinence in the past. Many
studies have shown a relationship between continence
surgery and OAB symptoms where the prevalence of de
novo OAB varied between 15% and 29% on the short
term (1–3 months postoperatively) [12, 13]a n d0 –30%
on the long term [12–14]. As in other studies, we found
Table 2 Prevalence of overactive bladder symptoms and any OAB
symptoms per age group
a
Frequency
b Urgency
c Urge
incontinence
d
Any of the OAB
symptoms
45–55 162 (25.3%) 193 (30.9%) 178 (27.7%) 298 (46.1%)
56–65 121 (28.4%) 141 (33.7%) 116 (26.9%) 200 (46.2%)
66–75 80 (35.9%) 92 (40.5%) 79 (35.0%) 126 (54.5%)
76–85 24 (37.5%) 33 (54.1%) 32 (48.5%) 42 (63.6%)
Overall 393 (28.7%) 463 (34.4%) 411 (29.8%) 677 (48.6%)
Data are presented as number of women (percentage)
aData on age category on 16 women are missing
bData on frequency on 28 women are missing
cData on urgency on 52 women are missing
dData on urge incontinence on 16 women are missing
Table 3 Prevalence of prolapse symptoms
e in women with symptoms
of OAB
Prolapse
symptoms
No prolapse
symptoms
P
a
Frequency
b 66 (41.8%) 320 (26.9%) 0.000
Urgency
c 77 (49.7%) 379 (32.4%) 0.000
Urge incontinence
d 64 (40.3%) 340 (28.3%) 0.003
Any of the OAB
symptoms
e
84 (69.4%) 588 (46.6%) 0.000
Data are presented as number of women (percentage)
aP value using chi-square test to compare the difference between women
with versus without prolapse symptoms.
bData on 28 women are missing
cData on 52 women are missing
dData on 16 women are missing
eData on four women are missing
fData on prolapse symptoms on 24 women are missing
Table 1 Patients’ characteristics and details of previous pelvic
operations
Number of women 1397
Age (years)
a
45–55 647 (46.9%)
56–65 435 (31.5%)
66–75 233 (16.9%)
76–85 66 (4.8%)
Parity
0 120 (8.6%)
1 215 (15.4%)
2 675 (48.3%)
≥3 387 (27.7%)
Body mass index (kg/m2)
b
<20 53 (3.9%)
20–25 599 (43.9%)
25–30 519 (38.0%)
≥30 193 (14.1%)
Race
c
Caucasian 1,351 (98.5%)
Non-Caucasian 20 (1.5%)
Smoking
Former smoking
d 326 (23.6%)
Current smoking
d 280 (20.3%)
Postmenopausal status 1,009 (72.2%)
Hormone suppletion
e 88 (6.4%)
Previous gynaecological surgery
Prolapse surgery
h 103 (7.4%)
Hysterectomy
i 234 (16.9%)
Incontinence surgery
j 47 (3.4%)
Data are presented as number of women (percentage)
aData on 16 women are missing
bData on 33 women are missing
cData on 26 women are missing
dData on 15 women are missing
eData on 30 women are missing
fData on 25 women are missing
gData on 18 women are missing
hData on 13 women are missing
iData on 14 women are missing
jData on 15 women are missing
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ing age [3, 8].
Overweight (body mass index [BMI] greater then 30)
was another independent risk factor for OAB symptoms.
This is consistent with other studies, who found the same
relationship [15–19]. The study of Cheung found a similar
OR for overweight [15], where the study of Lawrence
found a higher OR (2.73) [18]. On the other hand, Choo
et al. [16] found that BMI was only a predictor for OAB
dry (urgency with or without frequency or nocturia), but not
for OAB wet (urgency with urge incontinence, with or
without frequency or nocturia).
Another factor for achieving urgency was smoking.
Other studies are not conclusive about the role of smoking
in OAB [17, 20, 21]. The study of Bradley et al. [20] found
no relation between current smoking and urinary symp-
Table 4 Factors of the univariate logistic regression analysis on the various OAB symptoms
Frequency OR
(95% CI)
Urgency OR
(95% CI)
Urge incontinence OR
(95% CI)
Any OAB OR
(95% CI)
Age (years)
a 45–55 Ref Ref Ref Ref
56–65 1.2 (0.9, 1.5) 1.1 (0.9, 1.5) 1.0 (0.7,1.3) 1.0 (0.8, 1.3)
66–75 1.7 (1.2, 2.3) 1.5 (1.1, 2.1) 1.4 (1.0, 1.9) 1.4 (1.0, 1.9)
76–85 1.8 (1.0, 3.0) 2.6 (1.5, 4.5) 2.5 (1.5, 4.1) 2.0 (1.2, 3.5)
Parity ≤2 Ref Ref Ref Ref
>2 1.3 (1.0, 1.7) 1.0 (0.8, 1.3) 1.0 (0.8, 1.3) 1.2 (0.9, 1.5)
Body mass index (kg/m2)
b <20 0.7 (0.3,1.5) 0.4 (0.2, 1.0) 0.7 (0.4, 1.5) 0.6 (0.3, 1.0)
20–25 Ref Ref Ref Ref
25–30 1.6 (1.3, 2.1) 1.3 (1.0, 1.7) 1.5 (1.1, 1.9) 1.4 (1.1, 1.7)
≥30 2.0 (1.4, 2.8) 2.2 (1.6, 3.1) 2.2 (1.6, 3.1) 2.3 (1.7, 3.2)
Smoking
Former smoking
c Yes 1.3 (1.0, 1.8) 1.2 (0.9, 1.6) 1.0 (0.8, 1.4) 1.1 (0.8, 1.4)
No Ref Ref Ref Ref
Current smoking
c Yes 1.0 (0.8,1.4) 1.3 (1.0, 1.7) 1.3 (1.0, 1.7) 1.2 (1.0, 1.6)
No Ref Ref Ref Ref
Postmenopausal status Yes 1.5 (1.2, 2.0) 1.6 (1.2, 2.0) 1.4 (1.1, 1.8) 1.3 (1.0, 1.7)
No Ref Ref Ref Ref
Hormonal suppletion therapy
e Yes 1.2 (0.7, 1.9) 1.2 (0.7, 1.8) 0.7 (0.4, 1.2) 0.9 (0.6, 1.4)
No Ref Ref Ref Ref
Previous gynaecological surgery
Prolapse surgery
d Yes 2.5 (1.7, 3.8) 2.6 (1.7, 3.9) 1.9 (1.3, 2.9) 2.9 (1.9, 4.6)
No Ref Ref Ref Ref
Hysterectomy
h Yes 1.5 (1.1, 2.1) 1.3 (0.9, 1.7) 1.3 (1.0, 1.8) 1.3 (1.0, 1.7)
No Ref Ref Ref Ref
Incontinence surgery
c Yes 3.5 (1.9, 6.5) 3.4 (1.9, 6.3) 4.3 (2.3, 8.0) 6.5 (2.9, 14.5)
No Ref Ref Ref Ref
Prolapse symptoms
i Yes 2.0 (1.4, 2.7) 2.1 (1.5, 2.9) 1.7(1.2, 2.4) 2.6 (1.7, 3.9)
No Ref Ref Ref Ref
All values with P<0.05 are illustrated in bold
Ref: reference
aData on 16 women are missing
bData on 33 women are missing
cData on 15 women are missing
dData on 13 women are missing
eData on 30 women are missing
fData on 25 women are missing
gData on 18 women are missing
hData on 14 women are missing
iData on 24 women are missing
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current and former smoking was associated with urgency
[21]. One study found that current smokers were 1.44 time
morelikelytodevelop OAB,and the increased riskfor former
smokers was nearly significant [17]. The induction of OAB
in smoking could be related to an anti-oestrogenic hormonal
effect on the bladder and uretra [22] and a nicotine induced
phasic contraction of the detrusor muscle [23].
Postmenopausal status was a risk factor for the symptom
frequency in our study. This is consistent with another study
which found postmenopausal status to be a predictor for OAB
symptoms [24]. This can be explained because oestrogen has
an important role in the urogenital tract through oestrogen
receptors in urethra, bladder and pelvic floor [25], where defi-
ciency causes atrophic changes [26], which is associated with
OAB symptoms. Reversal of the atrophy by oestrogen treat-
ment can have a positive influence on OAB symptoms [27].
Surprisingly, we found previous prolapse surgery to be a
predictor for the symptom urgency, this in contrast to
practically all studies that showed an improvement of OAB
symptoms after prolapse surgery [5]. A possible explanation
for this finding is that women after prolapse surgery
achieved de novo urgency, as was found in 5% of the
patients in one study [28].
Strengths and weaknesses
The strong point about this study is that it is a large cross-
sectional study in a homogenic female population, which
made multivariate analysis possible; as a result, however,
Table 5 Risk factors on OAB symptoms after multivariate regression analysis
Frequency OR
(95% CI)
Urgency OR
(95% CI)
Urge incontinence OR
(95% CI)
Any OAB OR
(95% CI)
Age (years)
a 45–55 Ref Ref Ref
56–65 1.0 (0.8, 1.4) 0.9 (0.6, 1.1) 0.9 (0.7, 1.2)
66–75 1.4 (1.0, 2.0) 1.3 (0.9, 1.8) 1.3 (1.0, 1.8)
76–85 2.7 (1.5, 4.9) 2.2 (1.3, 3.8) 2.1 (1.2, 3.7)
Body mass index (kg/m
2)
b <20 0.7 (0.3, 1.6) 0.4 (0.2, 0.9) 0.7 (0.3, 1.5) 0.5 (0.3, 1.0)
20–25 Ref Ref Ref Ref
25–30 1.5 (1.1, 2.0) 1.2 (0.9, 1.6) 1.3 (1.0, 1.8) 1.3 (1.0, 1.6)
≥30 1.7 (1.2, 2.4) 2.2 (1.5, 3.1) 2.0 (1.4, 2.9) 2.2((1.5, 3.1)
Smoking
Smoking in the past
c Yes 1.4 (1.1, 1.9)
No Ref
Current smoking
c Yes 1.7 (1.2, 2.3) 1.4 (1.0, 1.8)
No Ref Ref
Postmenopausal status Yes 1.3 (1.0, 1.8)
No Ref
Previous gynaecological surgery
Prolapse surgery
d Yes 2.3 (1.4, 3.6)
No Ref
Incontinence surgery
e Yes 2.9 (1.5, 5.5) 4.3 (2.3, 8.2) 6.7 (2.8, 16.3)
No Ref Ref Ref
Prolapse symptoms
f Yes 2.4 (1.6, 3.5) 2.2 (1.4, 3.3) 1.8 (1.2, 2.6) 2.3 (1.5, 3.5)
No Ref Ref Ref Ref
Variance explained by the model
g 5.8% 8.8% 6.6% 9.1%
OR odds rario, Ref reference
aData on 16 women are missing
bData on 33 women are missing
cData on 15 women are missing
dData on 13 women are missing
eData on 18 women are missing
fData on 24 women are missing
gNagelkerke R
2
574 Int Urogynecol J (2011) 22:569–575genetic and racial factors could not be included, which is
also an inherent weakness of the design.
Another weakness of this study is that not all factors of
influence on OAB are included, such as food and beverages
(coffee and alcoholic consumption) and the use of OAB
therapies (bladder training and pharmacotherapy).
Conclusion
In this study, we found a prevalence of urgency of 34%, as
the core symptom of the OAB spectrum, and of any OAB
symptoms of 49%. POP symptoms are an independent risk
factor for OAB symptoms. Other risk factors are continence
surgery in the past, age above 75, overweight and smoking.
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